Announcement on the proposed non-implementation of a profit distribution plan in 2024
Lingkang Pharmaceutical: Announcement on not revising the “Lingkang Bonds” conversion price downward
Lingkang Pharmaceutical: An indicative announcement on the “Lingkang Bonds Transfer” expected to meet the revised conditions for the share conversion price
Lingkang Pharmaceutical: Convertible debt-to-equity conversion results and share change announcement
Lingkang Pharmaceutical: Announcement on not revising the “Lingkang Bonds” conversion price downward
Lingkang Pharmaceutical: An indicative announcement on the “Lingkang Bonds Transfer” expected to meet the revised conditions for the share conversion price
Lingkang Pharmaceutical: Announcement on not revising the “Lingkang Bonds” conversion price downward
Lingkang Pharmaceutical: An indicative announcement on the “Lingkang Bonds Transfer” expected to meet the revised conditions for the share conversion price
Lingkang Pharmaceutical: Announcement on not revising the “Lingkang Bonds” conversion price downward
Lingkang Pharmaceutical: Announcement on not revising the “Lingkang Bonds” conversion price downward
Lingkang Pharmaceutical: Announcement on the cancellation of the controlling shareholder\'s share pledge
Announcement on the cancellation of the controlling shareholder\'s share pledge
Announcement on the cancellation of the pledge of some of the shares of the controlling shareholder
Announcement on the deferral of the controlling shareholder\'s pledged share repurchase transaction
Announcement concerning the lifting of the pledge of shares by the controlling shareholder.
Announcement on the Delayed Repurchase of Stock Pledge Repurchase Transactions by the Controlling Shareholder.
Announcement on the proposed non-implementation of a profit distribution plan in 2023
Announcement on cancellation of pledge and re-application of pledge of some of the controlling shareholder\'s shares
Announcement on the implementation results of the share repurchase and changes in shares
Announcement on stock pledge repurchase transactions carried out by controlling shareholders